Literature DB >> 12415108

Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade.

Chi-Wai Wong1, Christopher McNally, Elliot Nickbarg, Barry S Komm, Boris J Cheskis.   

Abstract

Numerous studies have demonstrated that estrogens induce rapid and transient activation of the Src/Erk phosphorylation cascade. Activation of this cascade triggers vital cellular functions including cell proliferation and differentiation. However, the details of the molecular mechanism of this process remain to be elucidated. We have identified a previously uncharacterized nuclear receptor-interacting protein designated as modulator of nongenomic activity of estrogen receptor (MNAR). Here we show that MNAR modulates estrogen-receptor (ER) interaction with members of the Src family of tyrosine kinases, which leads to a stimulation of Src enzymatic activity and activation of Erk1 and Erk2 kinases. We also show that MNAR, through activation of the Src/Erk phosphorylation cascade, affects ER transcriptional activity and ultimately ER-mediated gene expression. These data reveal that MNAR mediates the crosstalk between two important classes of signal transducing molecules and suggest that ER "genomic" and "nongenomic" activities are interrelated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12415108      PMCID: PMC137496          DOI: 10.1073/pnas.192569699

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Mammalian MAP kinase signalling cascades.

Authors:  L Chang; M Karin
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

2.  Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins.

Authors:  M Matsuda; B J Mayer; Y Fukui; H Hanafusa
Journal:  Science       Date:  1990-06-22       Impact factor: 47.728

Review 3.  Oncogenes and signal transduction.

Authors:  L C Cantley; K R Auger; C Carpenter; B Duckworth; A Graziani; R Kapeller; S Soltoff
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

4.  Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.

Authors:  R K Vadlamudi; R A Wang; A Mazumdar; Y Kim; J Shin; A Sahin; R Kumar
Journal:  J Biol Chem       Date:  2001-07-31       Impact factor: 5.157

5.  Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway.

Authors:  W Feng; P Webb; P Nguyen; X Liu; J Li; M Karin; P J Kushner
Journal:  Mol Endocrinol       Date:  2001-01

6.  Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.

Authors:  E J Filardo; J A Quinn; K I Bland; A R Frackelton
Journal:  Mol Endocrinol       Date:  2000-10

7.  Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases.

Authors:  V Boonyaratanakornkit; M P Scott; V Ribon; L Sherman; S M Anderson; J L Maller; W T Miller; D P Edwards
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

8.  Structure-function evaluation of ER alpha and beta interplay with SRC family coactivators. ER selective ligands.

Authors:  C W Wong; B Komm; B J Cheskis
Journal:  Biochemistry       Date:  2001-06-12       Impact factor: 3.162

9.  Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation.

Authors:  Robert X-D Song; Robert A McPherson; Liana Adam; Yongde Bao; Margaret Shupnik; Rakesh Kumar; Richard J Santen
Journal:  Mol Endocrinol       Date:  2002-01

10.  Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation.

Authors:  A Migliaccio; G Castoria; M Di Domenico; A de Falco; A Bilancio; M Lombardi; M V Barone; D Ametrano; M S Zannini; C Abbondanza; F Auricchio
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

View more
  103 in total

Review 1.  Estrogen, efferent ductules, and the epididymis.

Authors:  Avenel Joseph; Barry D Shur; Rex A Hess
Journal:  Biol Reprod       Date:  2010-10-06       Impact factor: 4.285

Review 2.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

3.  Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines.

Authors:  Claudia Bocca; Francesca Bozzo; Andrea Bassignana; Antonella Miglietta
Journal:  Mol Cell Biochem       Date:  2010-12-08       Impact factor: 3.396

4.  Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapy.

Authors:  Brian J Park; Zakary L Whichard; Seth J Corey
Journal:  Cancer Lett       Date:  2012-02-02       Impact factor: 8.679

Review 5.  Extranuclear signaling by estrogen: role in breast cancer progression and metastasis.

Authors:  V Cortez; M Mann; D W Brann; R K Vadlamudi
Journal:  Minerva Ginecol       Date:  2010-12

Review 6.  Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.

Authors:  Mostafa A Borahay; Ayman Al-Hendy; Gokhan S Kilic; Darren Boehning
Journal:  Mol Med       Date:  2015-04-13       Impact factor: 6.354

7.  Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.

Authors:  Jian-Hua Zhou; David V Yu; Jingwei Cheng; David J Shapiro
Journal:  Steroids       Date:  2007-07-07       Impact factor: 2.668

Review 8.  Proteins of multiple classes may participate in nongenomic steroid actions.

Authors:  Cheryl S Watson; Bahiru Gametchu
Journal:  Exp Biol Med (Maywood)       Date:  2003-12

9.  Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.

Authors:  Ratna K Vadlamudi; Seetharaman Balasenthil; Russell R Broaddus; Jan-Ake Gustafsson; Rakesh Kumar
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

Review 10.  Nongenomic steroid-triggered oocyte maturation: of mice and frogs.

Authors:  James Deng; Liliana Carbajal; Kristen Evaul; Melissa Rasar; Michelle Jamnongjit; Stephen R Hammes
Journal:  Steroids       Date:  2008-11-24       Impact factor: 2.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.